EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The Circadian Biology of Heart Failure

Nadim El Jamal iD, Ronan Lordan iD, Sarah L Teegarden, Tilo Grosser iD, Garret FitzGerald iD

Circulation Research · 20.01.2023 · 132 (2) · 223-237

DOI: 10.1161/circresaha.122.321369 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 20.01.2023. Verfasst von Nadim El Jamal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Translational Medicine and Therapeutics (N.E.J., R.L., S.L.T., T.G., G.F.), Perelman School of Medicine, University of Pennsylvania, Ph…. Hauptthemen laut MEDLINE: Heart Failure, Circadian Clocks. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Driven by autonomous molecular clocks that are synchronized by a master pacemaker in the suprachiasmatic nucleus, cardiac physiology fluctuates in diurnal rhythms that can be partly or entirely circadian. Cardiac contractility, metabolism, and electrophysiology, all have diurnal rhythms, as does the neurohumoral control of cardiac and kidney function. In this review, we discuss the evidence that circadian biology regulates cardiac function, how molecular clocks may relate to the pathogenesis of heart failure, and how chronotherapeutics might be applied in heart failure. Disrupting molecular clocks can lead to heart failure in animal models, and the myocardial response to injury seems to be conditioned by the time of day. Human studies are consistent with these findings, and they implicate the clock and circadian rhythms in the pathogenesis of heart failure. Certain circadian rhythms are maintained in patients with heart failure, a factor that can guide optimal timing of therapy. Pharmacologic and nonpharmacologic manipulation of circadian rhythms and molecular clocks show promise in the prevention and treatment of heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCircadian ClocksAnimalsHumansCircadian RhythmHeartBiology

Stichwörter der Autor:innen

biological clockschronotherapycircadian clockscircadian rhythmheart failure

Autor:innen und Institutionen

  • Institute for Translational Medicine and Therapeutics (N.E.J., R.L., S.L.T., T.G., G.F.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Department of Systems Pharmacology and Translational Therapeutics (N.E.J., R.L., S.L.T., G.F.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Department of Medicine (N.E.J., R.L., S.L.T., G.F.), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Department of Translational Pharmacology, Bielefeld University, Germany (T.G.).

ORCID-Profile: Nadim El Jamal, Ronan Lordan, Tilo Grosser, Garret FitzGerald

Förderung

  • NCATS NIH HHS

Zitieren

APA

El Jamal, N., Lordan, R., Teegarden, S. L., Grosser, T., & FitzGerald, G. (2023). The Circadian Biology of Heart Failure. Circulation Research, 132(2), 223-237. https://doi.org/10.1161/circresaha.122.321369

Vancouver

El Jamal N, Lordan R, Teegarden SL, Grosser T, FitzGerald G. The Circadian Biology of Heart Failure. Circulation Research. 2023;132(2):223-237. doi:10.1161/circresaha.122.321369

BibTeX
@article{ElJamal2023,
  author = {El Jamal, Nadim and Lordan, Ronan and Teegarden, Sarah L and Grosser, Tilo and FitzGerald, Garret},
  title = {The Circadian Biology of Heart Failure},
  journal = {Circulation Research},
  year = {2023},
  volume = {132},
  number = {2},
  pages = {223--237},
  doi = {10.1161/circresaha.122.321369}
}
Kostenlos starten →